Topics

Clinical trials have to have limits. But when a drug for an untreatable disease is being tested, the demand is overwhelming. On a Huntington's disease trial, and patients who could or couldn't enroll, with multimedia from @Matthew_Orr @DomnicSmithy http

09:38 EST 4 Dec 2019 | STAT

Clinical trials have to have limits. But when a drug for an untreatable disease is being tested, the demand is overwhelming. On a Huntington's disease trial, and patients who could or couldn't enroll, with multimedia from https://www.statnews.com/2019/12/04/a-clinical-trial-for-huntingtons-opens-the-door-to-hope-for-some-patients-but-only-so-many-can-get-in/ …

Original Article: Clinical trials have to have limits. But when a drug for an untreatable disease is being tested, the demand is overwhelming. On a Huntington's disease trial, and patients who could or couldn't enroll, with multimedia from @Matthew_Orr @DomnicSmithy http

NEXT ARTICLE

More From BioPortfolio on "Clinical trials have to have limits. But when a drug for an untreatable disease is being tested, the demand is overwhelming. On a Huntington's disease trial, and patients who could or couldn't enroll, with multimedia from @Matthew_Orr @DomnicSmithy http"

Quick Search

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Huntington's Disease
Huntington's disease is a hereditary disease caused by a defect in a single gene on Chromosome 4 that is inherited in an autosomal dominant fashion. The defect causes a part of DNA, called a CAG repeat, to occur many more times than it is supposed to...